-
-
-
-
-
-
-
Argus Starts 10X Genomics (TXG) at Buy
-
-
-
-
-
-
-
10x Genomics (TXG) Tops Q2 EPS by 10c, Beats on Revenue
-
-
-
-
-
-
-
William Blair Upgrades 10X Genomics (TXG) to Outperform
-
-
-
-
-
-
-
10X Genomics (TXG) PT Lowered to $20 at Leerink Partners
-
-
-
-
-
-
-
10x Genomics (TXG) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
-
-
-
-
-
-
-
10x Genomics (TXG) 999 contracts of August 17.50 calls trade
-
479,047 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


